Valeant Hit With Chancery Suit Over Libido Drug Marketing
By Matt Chiappardi ( November 2, 2016, 7:36 PM EDT) -- Former shareholders of Sprout Pharmaceuticals Inc. heaved a Delaware Chancery lawsuit at Valeant Pharmaceuticals International Inc. on Wednesday, alleging that the drugmaker did a lousy job marketing and developing their former company's female libido pill that Valeant promised to shepherd when it bought Sprout in 2015 for $1 billion....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.